This activity is presented by outstanding educators in the field of lipidology and preventive cardiology. Join Drs. Erin D. Michos, James A. Underberg, and Nathan D. Wong for a deep dive into these hot topics: new pathways to manage high risk in ASCVD, differential biological effects of omega-3 fatty acids, and practical considerations to manage ASCVD risk.
- Host: Erin D. Michos, MD, MHS, FACC, FAHA, FASE
- Guest: James A. Underberg, MD
- Guest: Nathan D. Wong, PhD, MPH
We are in a new era of ASCVD prevention! Discover new approaches to assess and manage risk, the biological effects of omega-3 fatty acids, and more.
Available credits: 0.50
In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC
Director of Women’s Cardiovascular Health
Associate Director of Preventive Cardiology
Associate Professor of Medicine and Epidemiology
Ciccarone Center for the Prevention of Cardiovascular Disease
Division of Cardiology
Johns Hopkins School of Medicine
No relationships reported.
James A. Underberg, MD, MS
Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for Prevention of Cardiovascular Disease
Director, Bellevue Hospital Lipid Clinic
President, National Lipid Association
New York, NY
Consulting Fees: Amgen, Esperion, Novartis
Speakers Bureau: Alexion, Amarin, Amgen, Amryt Pharma, Esperion
Contracted Research: Amryt Pharma
Nathan D. Wong, PhD, FACC, FAHA, FNLA, FASPC
Past President, American Society for Preventive Cardiology
Professor and Director
Heart Disease Prevention Program
Division of Cardiology
University of California, Irvine School of Medicine
Contracted Research: Amarin, Amgen, Esperion, Novartis
Consulting Fees: Novartis
Speaker Bureau: Amarin, Esperion
- Ben Caref, PhD, has nothing to disclose.
- Libby Lurwick has nothing to disclose.
- Milly Marte has nothing to disclose.
- Erin Michos has nothing to disclose.
After participating in this educational activity, participants should be better able to:
- Have greater competence on risk stratifying patients for potential ASCVD events
- Describe the impact of recent randomized cardiovascular outcomes trials to reduce ASCVD risk
- Appreciate the difference between omega-3 fatty acids and their formulations to impact ASCVD events, including the negative role of dietary supplements
- Apply evidence-based guidelines, recent trial evidence, and cost utility of ASCVD therapy in practice
This activity is designed to meet the educational needs of internists, primary care physicians, hospitalists, and allied healthcare professionals, including pharmacists, nurse practitioners, physician assistants, dietitians, and nurses.
Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Global Learning Collaborative designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Dedicated to the creation and execution of the highest quality, evidence-based continuing medical education (CME) initiatives, we utilize multiple learning opportunities for the primary goal of improving healthcare delivered to patients through sharing of research, knowledge, and clinical practice skills.
This activity is supported by an independent educational grant from Amarin Pharma, Inc.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medtelligence. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Medtelligence you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction of this material is not permitted without written permission from the copyright owner.
Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.